A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

NCT04309578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Gastric or Gastroesophageal Junction(GEJ) Adenocarcinoma

Interventions

DRUG: Trastuzumab, Capecitabine and Cisplatin

Sponsor

Asan Medical Center